Stool sample may predict survival in ICU patients
NCT ID NCT07658001
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study looks at whether measuring lactate in stool can help doctors predict how well critically ill patients with low blood flow will respond to treatment. About 40 adults in the ICU will provide a stool sample within 24 hours of admission. Researchers will check if high stool lactate levels are linked to worse outcomes, such as needing more medication or organ failure. The goal is to find a simple, noninvasive way to guide care early on.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital H+ Querétaro
Querétaro City, Querétaro, 76000, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk
- Can brain waves predict thinking problems after sepsis?
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?